Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)

Bausch Health Companies (BHC) reported Amortizatization of Intangibles of $3.2 million for Q1 2012, up 22.98% on a YoY basis from $2.6 million in Q2 2011, and up 63.51% sequentially from $2.0 million in Q4 2011.

Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends

Bausch Health Companies (BHC) has 4 years of Amortizatization of Intangibles data on file, last reported at $3.2 million in Q1 2012.

  • For the quarter ending Q1 2012, Amortizatization of Intangibles rose 22.98% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2012 stood at $9.1 million (down 17.37% YoY), and the FY2011 full-year result was $8.5 million, down 23.98% from the prior year.
  • Amortizatization of Intangibles rose to $3.2 million in Q1 2012, from $2.0 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q1 2012 to a low of $564000.0 in Q2 2009.
  • A 4-year average of $2.4 million and a median of $2.7 million in 2009 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles jumped 403.01% in 2010 and plunged 31.44% in 2011, its largest moves.
  • Tracing BHC's Amortizatization of Intangibles over 4 years: stood at $2.7 million in 2009, then grew by 2.88% to $2.8 million in 2010, then retreated by 29.51% to $2.0 million in 2011, then jumped by 63.51% to $3.2 million in 2012.
  • Business Quant data shows BHC's Amortizatization of Intangibles at $3.2 million in Q1 2012, $2.0 million in Q4 2011, and $1.9 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Bausch Health Companies 1.68 Bn 367.46 Mn 2.52 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2012 3.25 Mn
Mar 31, 2012 3.25 Mn
Dec 31, 2011 1.99 Mn
Dec 31, 2011 1.99 Mn
Sep 30, 2011 1.92 Mn
Sep 30, 2011 1.92 Mn
Jun 30, 2011 1.95 Mn
Jun 30, 2011 1.95 Mn
Mar 31, 2011 2.64 Mn
Mar 31, 2011 2.64 Mn
Dec 31, 2010 2.82 Mn
Dec 31, 2010 2.82 Mn
Sep 30, 2010 2.71 Mn
Sep 30, 2010 2.71 Mn
Jun 30, 2010 2.84 Mn
Jun 30, 2010 2.84 Mn
Mar 31, 2010 2.80 Mn
Mar 31, 2010 2.80 Mn
Dec 31, 2009 2.74 Mn
Dec 31, 2009 2.74 Mn